FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC)

CUSIP: 31447P100

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common stock, no par value (the "Shares")
Shares outstanding
34,145,841
Total 13F shares
16,048,764
Share change
+1,106,621
Total reported value
$101,424,546
Price per share
$6.32
Number of holders
64
Value change
+$7,283,101
Number of buys
37
Number of sells
24

Quarterly Holders Quick Answers

What is CUSIP 31447P100?
CUSIP 31447P100 identifies FENC - FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC) as of Q4 2024

As of 31 Dec 2024, FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC) was held by 64 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,048,764 shares. The largest 10 holders included Southpoint Capital Advisors LP, Sonic GP LLC, Solas Capital Management, LLC, Rosalind Advisors, Inc., BlackRock, Inc., DG Capital Management, LLC, VANGUARD GROUP INC, HARBERT FUND ADVISORS, INC., MORGAN STANLEY, and STATE STREET CORP. This page lists 64 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.